Skip to main content
Screener/Healthcare/Biotechnology

IOVA — Iovance Biotherapeutics, Inc.

NASDAQ
$6.26+0.05 (+0.81%)
Mid CapUnder $10HealthcareLow Beta
$1.76
$6.92
$5.88
$6.92
EPS (TTM)$-1.09
P/E Ratio-3.52
Dividend Yield—
Market Cap$2.09B
Volume27.35M
Prev Close$6.21
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$86.8M-$71.9M$-0.15215.9%-82.9%
Q3 '25$67.5M-$91.3M$-0.2597.9%-135.3%
Q2 '25$60.0M-$111.7M$-0.335.5%-186.2%
Q1 '25$49.3M-$116.2M$-0.36-0.8%-235.5%
Q4 '24$73.7M-$78.6M$-0.2638.2%-106.6%
Q3 '24$58.6M-$83.5M$-0.2832.0%-142.7%
Q2 '24$31.1M-$97.1M$-0.34-0.8%-312.2%
Q1 '24$715K-$113.0M$-0.42-915.5%-15800.8%
Get Your Daily Market Recap